Tsontcho A Ianchulev, MD
- PROFESSOR | Ophthalmology
- Ophthalmology (Eye)
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Queens
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- Mount Sinai Beth Israel
- New York Eye and Ear Infirmary of Mount Sinai 212-979-4500 212-979-4500
Book an Appointment - Tsontcho A Ianchulev, MD
Dr. Ianchulev is a Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and Director of Ophthalmic Innovation and Technology at the New York Eye and Ear Infirmary of Mount Sinai. As an inventor, researcher and developer, he is one of the top innovators in the field – his breakthrough research and inventions have resulted in major advances in ophthalmology, which have transformed the treatment paradigms in retina, glaucoma and have led to new FDA approved therapies benefiting hundreds of thousands of patients every year.
Dr. Ianchulev was the principal scientist who designed and lead the clinical research of Lucentis - the first antibody therapy in ophthalmology for the treatment of wet AMD, diabetic macular edema, and retinal vein occlusions. He is also the founder of intraoperative aberrometry – the advanced biometry surgical guidance system for high precision cataract surgery. He was also developed and introduced in the US the CyPass micro-stent – the first MIGS supraciliary implant to receive FDA approval. Dr. Ianchulev is also the founder of a new technology for micro-interventional cataract surgery (miLOOP, Iantech, Inc), as well as the specialty biopharma Eyenovia, Inc, which is developing new therapeutic approaches for front-of-the-eye disease. His milestone publications have been cited by more than 2,000 peer-review papers. Dr. Ianchulev is an invited speaker at many international meetings and panels and has been an invited expert by the US Congress on matters on policies related to healthcare, technology and innovation.
As a clinician, Dr. Ianchulev provides specialized clinical and surgical care for patients with glaucoma and cataract as well as consultations for complex and refractory cases. Patients trust Dr. Ianchulev's expertise because he consistently provides high quality care that leads to positive and lasting health outcomes. He is sensitive to the uniqueness of each patient's situation and adapts his consultations and treatment options appropriately to accommodate individual needs and concerns.
- Allergic Eye Problems
- Angle-Closure Glaucoma
- Cataract Removal
- Cataract Surgery
- Comprehensive Dilated Eye Exam
- Contact Dermatitis
- Corneal Opacity
- Diabetes Insipidus
- Double Vision
- Dry Eye Disease
- Eye Emergency Visit
- Eye Infection
- Eye Inflammation
- Eye Trauma / Removal of Foreign Body / Corneal Abrasion
- Eye Tumor
- Eyelid Cancer
- Glaucoma Surgery
- Nearsightedness And Farsightedness
- Open-Angle Glaucoma
- Ophthalmic Pathology
- Orbital Fracture/Trauma
- Short-sightedness / Myopia
- Vision Loss
MD, Harvard University Medical School
Internship, Internal Medicine
Lahey Clinic Hospital
Doheny Eye Institute
Spanish, German, Bulgarian, Russian, English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ianchulev during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Eyenovia Inc
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Scientific Advisory Board:
- Perfect Lens
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Aeye, Inc.
- Eyenovia Inc
- Iantrek, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.